The Importance of Targeted Drug Delivery Systems on Pancreatic Cancer
Current Journal of Applied Science and Technology · pp. 2400–2416 · Published 17 Apr 2014
10.9734/BJAST/2014/9671Abstract
Pancreatic cancer (PC) is the fourth type of cancer-related death in the world. There is estimated 45,220 new cases of PC will be diagnosed and 38,460 people will be passed away from the disease in the near future. The absence of diagnostic and prognostic markers and also unresponsiveness to current therapies including radiation and chemotherapies are major barriers against successful therapy even in the initial stage. The current therapies is not sufficient to provide effective treatment for PC patients due torapiddrug solubility and metabolism, insufficient drug concentration at the specific site and adverse side effects. To eliminate this disadvantages, nanoparticle based drug delivery systems have been investigated.In this review, we try to reveal the genetic and molecular mechanism which cause PC and emphasize the importance of targeted drug delivery systems for the disease.
Cited by 0
No indexed citations yet.
Related research
- Application of Peptide-Conjugated Photosensitizers for Photodynamic Cancer Therapy: A Review — shares topic coverage
- Mulberry (Morus spp.): A Comprehensive Review of Its Medicinal and Functional Properties — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.